LI Hao 1,2 , ZHU Zunyi 1,2 , XIE Han 2,3 , GE Weihong 2,3
  • 1. Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing 210029, P. R. China;
  • 2. Department of Pharmacy, Affiliated Drum Tower Hospital of Nanjing University, Nanjing 210008, P. R. China;
  • 3. Nanjing Medical Center of Clinical Pharmacy, Affiliated Drum Tower Hospital of Nanjing University, Nanjing 210008, P. R. China;
GE Weihong, Email: glg6221230@163.com
Export PDF Favorites Scan Get Citation

The American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) published the first clinical practice guideline for sudden sensorineural hearing loss in 2012 and updated it in 2019. The guideline, which includes 13 expert consensus recommendations and treatment protocols, advocates medication (glucocorticoids are the sole optional medicine) and hyperbaric oxygen therapy. In order to provide references for the formulation of the guidelines for sudden sensorineural hearing loss that are more suitable for our national conditions, this article interprets the treatment regimens of the guideline.

Citation: LI Hao, ZHU Zunyi, XIE Han, GE Weihong. Therapeutic regimen interpretation of American AAO-HNSF guidelines for sudden hearing loss (2019 update). Chinese Journal of Evidence-Based Medicine, 2023, 23(7): 755-759. doi: 10.7507/1672-2531.202211112 Copy

  • Previous Article

    Evidence-based practice points: drugs for confirmed COVID-19
  • Next Article

    Predictive model development and validation of recurrent hernias in patients after laparoscopic hernia repair: an 8-year retrospective study